Drugs / Interferon-2A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01404936 | Jul 1996 → Dec 2011 | lymphoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon-2A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01404936 ↗ |
| Route | Subcutaneous | “4 (x106 IU/m\^2) subcutaneously on days 1-4.” NCT01404936 ↗ |